Aberrant methylation of the SPARC gene has been reported in various kinds of tumors, including lung and colorectal cancer, acute myeloid leukemia, multiple myeloma, endometrial cancer, ovarian cancer, cervical cancer, pancreatic cancer, and prostate cancer [18-25]. This evidence concerns the gene SPARC and colorectal cancer.